Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing-Reference-Cited by-同舟云学术

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Published:2019-07-10 Issue:9 Volume:8 Page:643-653
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Lommerse Jos¹,Clarke Diana²,Kerbusch Thomas¹,Merdjan Henri³,Witjes Han¹,Teppler Hedy⁴,Mirochnick Mark⁵,Acosta Edward P.⁶,Wenning Larissa⁴,Nachman Sharon⁷,Chain Anne⁸

Affiliation:

1. Certara Strategic Consulting Oss The Netherlands

2. Boston Medical Center Boston Massachusetts USA

3. Certara Strategic Consulting Paris France

4. Merck & Co., Inc. Upper Gwynedd Pennsylvania USA

5. Boston University School of Medicine Boston Massachusetts USA

6. University of Alabama at Birmingham Birmingham Alabama USA

7. State University of New York Stony Brook New York USA

8. Merck & Co., Inc. Rahway New Jersey USA

Funder

National Institute of Child Health and Human Development

National Institute of Mental Health

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12443

Reference29 articles.

1. United Nations Programme on HIV and AIDS. UNAIDS fact sheet – 2017 global HIV statistics

2. Prevention of Mother-to-Child HIV-1 Transmission—Why We Still Need a Preventive HIV Immunization Strategy

3. Panel on Opportunistic Infections in HIV‐Exposed and HIV‐Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV‐exposed and HIV‐infected children

4. Clarke D.F.et al.Raltegravir pharmacokinetics and safety in HIV‐1 exposed neonates: dose‐finding study. Conference on Retroviruses and Opportunistic Infections Seattle WA February 13‐16 2017.

5. Isentress [prescribing information]. (2017). Accessed November 8 2018.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Supporting Prospective Pregnancy Trials via Modeling and Simulation: Lessons From the Past and Recommendations for the Future;The Journal of Clinical Pharmacology;2023-06

3. Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir;Clinical Pharmacokinetics;2021-02-02

4. A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV;CPT: Pharmacometrics & Systems Pharmacology;2021-01-25

5. Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097;JAIDS Journal of Acquired Immune Deficiency Syndromes;2020-12-15